These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11788219)

  • 21. Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions.
    Ahmed JM; Mintz GS; Waksman R; Lansky AJ; Mehran R; Wu H; Weissman NJ; Pichard AD; Satler LF; Kent KM; Leon MB
    Am J Cardiol; 2001 May; 87(10):1145-9. PubMed ID: 11356387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS.
    Waksman R; Ajani AE; Pinnow E; Cheneau E; Leborgne L; Dieble R; Bui AB; Satler LF; Pichard AD; Kent KK; Lindsay J
    Circulation; 2002 Aug; 106(7):776-8. PubMed ID: 12176945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial.
    Teirstein PS; Massullo V; Jani S; Popma JJ; Russo RJ; Schatz RA; Guarneri EM; Steuterman S; Sirkin K; Cloutier DA; Leon MB; Tripuraneni P
    Circulation; 2000 Feb; 101(4):360-5. PubMed ID: 10653825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial intravascular ultrasound assessment of the efficacy of intracoronary gamma radiation for preventing recurrent in-stent restenosis.
    Ahmed JM
    Minerva Cardioangiol; 2002 Oct; 50(5):507-15. PubMed ID: 12384633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
    Prpic R; Teirstein PS; Reilly JP; Moses JW; Tripuraneni P; Lansky AJ; Giorgianni JA; Jani S; Wong SC; Fish RD; Ellis S; Holmes DR; Kereiakas D; Kuntz RE; Leon MB
    Circulation; 2002 Oct; 106(18):2340-5. PubMed ID: 12403664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intracoronary radiation therapy in controlled and open clinical trials with afterloading systems and "hot" balloon catheters. Analysis of 6,692 patients].
    Silber S
    Herz; 2002 Feb; 27(1):30-55. PubMed ID: 11951794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
    Costantini CO; Lansky AJ; Mintz GS; Shirai K; Dangas G; Mehran R; Fahy M; Slack S; Coral M; Teirstein PS; Waksman R; Stone G; Moses J; Leon MB
    J Am Coll Cardiol; 2003 May; 41(10):1725-31. PubMed ID: 12767655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and determinants of the long-term beta intracoronary brachytherapy results.
    Witkowski A; Kalińczuk Ł; Chmielak Z; Łyczek J; Pregowski J; Kawczyńska M; Bulski W; Kulik A; Kepka C; Kruk M; Pszona S; Rózyłło W
    Kardiol Pol; 2005 Jun; 62(6):545-557; discussion 558. PubMed ID: 16123848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus.
    Gruberg L; Waksman R; Ajani AE; Kim HS; White RL; Pinnow EE; Satler LF; Pichard AD; Kent KM; Lindsay J
    J Am Coll Cardiol; 2002 Jun; 39(12):1930-6. PubMed ID: 12084590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
    Lee SW; Park SW; Park DW; Lee SW; Kim SH; Jang JS; Jeong YH; Kim YH; Lee CW; Hong MK; Yun SC; Kim JJ; Park SJ
    Am J Cardiol; 2007 Aug; 100(3):425-30. PubMed ID: 17659922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographical miss during centered intracoronary beta-radiation with 90Yttrium: incidence and implications for recurrence rates after vascular brachytherapy for de novo lesions.
    Sianos G; Wijns W; de Feyter PJ; Serruys PW
    Int J Cardiovasc Intervent; 2003; 5(4):181-9. PubMed ID: 14630560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracoronary radiation with gamma wire inhibits recurrent in-stent restenosis.
    Waksman R; Bhargava B; Chan RC; Sherman W; Pisch J; Mintz GS; Lansky AJ; Ahmed J; Ricci NA; Liprie SF
    Cardiovasc Radiat Med; 2001; 2(2):63-8. PubMed ID: 11340009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of device selection on angiographic outcomes for the treatment of in-stent restenosis. A sub analysis from the Washington Radiation for In-Stent restenosis Trial (WRIST).
    Zimarino M; Ajani AE; Marazia S; Pichard AD; Satler LF; De Caterina R; Barsotti A; Waksman R
    Ital Heart J; 2002 Apr; 3(4):256-62. PubMed ID: 12025375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.
    Silber S; Popma JJ; Suntharalingam M; Lansky AJ; Heuser RR; Speiser B; Teirstein PS; Bass T; O'Neill W; Lasala J; Reisman M; Sharma SK; Kuntz RE; Bonan R;
    Am Heart J; 2005 Apr; 149(4):689-94. PubMed ID: 15990754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Bunkheila F; Lombardo E; Pini S; Marrozzini C; Palmerini T; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):433-8. PubMed ID: 15558757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence.
    Kuiper KK; Salem M; Rotevatn S; Mills J; Nordrehaug JE
    Cardiovasc Revasc Med; 2007; 8(1):9-14. PubMed ID: 17293263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of 32P beta brachytherapy failure in patients with high-risk in-stent restenosis.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Bunkheila F; Neri S; Lombardo E; Marrozzini C; Pini S; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Cardiovasc Radiat Med; 2004; 5(2):77-83. PubMed ID: 15464944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year angiographic follow-up of intracoronary Sr90 therapy for restenosis prevention after balloon angioplasty.
    Meerkin D; Joyal M; Tardif JC; Lespérance J; Arsenault A; Lucier G; Bonan R
    Circulation; 2002 Jul; 106(5):539-43. PubMed ID: 12147533
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.